To achieve capital growth.
Name | % Net Assets |
---|---|
Beximco Pharmaceuticals | 5.6% |
Alliance Pharmaceuticals | 3.9% |
Eckoh | 3.8% |
Northern Petroleum | 3.6% |
Velosi | 3.1% |
RCG Holdings | 3.1% |
Faroe Petroleum | 2.8% |
Gulfsands Petroleum | 2.8% |
Norman Hay | 2.7% |
Tristel | 2.6% |
Key | % Net Assets |
---|---|
Beximco Pharmaceuticals | 5.6% |
Alliance Pharmaceuticals | 3.9% |
Eckoh | 3.8% |
Northern Petroleum | 3.6% |
Other | 83.1% |
Date | 21-Nov-2024 |
---|---|
NAV | 341.60p |
Currency | GBP |
Change | -1.80p |
% | -0.52% |
YTD change | -12.30p |
YTD % | -3.48% |
Fund Inception | 05/10/2005 |
---|---|
Fund Manager | Paul Mumford |
TER | 0.89 (15-Nov-2011) |
Minimum Investment | |
---|---|
Initial | £2500 |
Additional | £5,000 |
Savings | n/a |
Charges | |
---|---|
Initial | 5.00% |
Annual Mang't | 0.75% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | -0.01 |
You are here: research